Selcia Overview
- Founded
- 2001

- Status
- Acquired/Merged
- Employees
- 8

- Latest Deal Type
- M&A
- Financing Rounds
- 3
Selcia General Information
Description
Provider of drug discovery services intended to identifying the active ingredient by serendipitous discovery. The company's services include lead discovery, medicinal chemistry services, proprietary fragment screening and other related services, enabling pharma, biotechnology companies and academic institutions to receive integrated drug discovery services. The company also provides radiolabelling and chemical analytical services.
Contact Information
(Operating Subsidiary)
- Fyfield Business And Research Park
- Fyfield Road
- Ongar CM5 0GS
- England, United Kingdom
Selcia Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Selcia‘s full profile, request access.
Request a free trialSelcia Comparisons
Industry
0000000
0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSelcia Competitors (5)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Covance | Private Equity-Backed | Ann Arbor, MI | 00000 | 0000000 0000 | ||
0000 | Corporation | Dublin, Ireland | 00000 | 00000 | 000000000 | 00000 |
00000000 | Private Equity-Backed | Guildford, United Kingdom | 000 | 000000000 | ||
000 | Corporation | Chapel Hill, NC | 000 | 0000000000 | ||
0000000 00000000 | Private Equity-Backed | Orlando, FL | 000 | 000000000000 |
Selcia Patents
Selcia Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-0816759-D0 | Compounds | Ceased | 12-Sep-2008 | 0000000000 | |
US-20110184011-A1 | Compounds | Abandoned | 12-Sep-2008 | 0000000000 | 0 |
EP-2361253-A1 | Compounds | Withdrawn | 12-Sep-2008 | C07D471/04 |
Selcia Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Hans Fliri Ph.D | Chief Executive Officer & Chairman | ||
Clive Cornell | Chief Operating Officer & Co-Founder | ||
Dave Roberts | Business Development Director & Co-Founder |
Selcia Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000 00000 00.0 | Selcia | Chief Executive Officer & Chairman | 000 0000 |
Selcia Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSelcia Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Selcia‘s full profile, request access.
Request a free trial